{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:48:03Z","timestamp":1773920883807,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bj.2020.05.021","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T08:20:33Z","timestamp":1590826833000},"page":"341-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines"],"prefix":"10.1016","volume":"43","author":[{"given":"Hsin-I","family":"Shih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Jung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-3102","authenticated-orcid":false,"given":"Chia-Yu","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2020.05.021_bib1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of 2019 novel coronavirus infection in China","volume":"383","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2020.05.021_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","author":"Lechien","year":"2020","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.bj.2020.05.021_bib3","series-title":"Laboratory testing for coronavirus disease (COVID-19) in suspected human cases, Interium guidance","year":"2020"},{"key":"10.1016\/j.bj.2020.05.021_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cmi.2020.04.001","article-title":"Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay","volume":"26","author":"Yan","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bj.2020.05.021_bib5","series-title":"Laboratory guidelines for the detection and diagnosis of COVID-19 virus infection","year":"2020"},{"key":"10.1016\/j.bj.2020.05.021_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00722-20","article-title":"Report from the American society for microbiology COVID-19 international summit, 23 march 2020: value of diagnostic testing for SARS-CoV-2\/COVID-19.","volume":"11","author":"Patel","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.bj.2020.05.021_bib7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 Viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2020.05.021_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.3786","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2020.05.021_bib9","article-title":"Prolonged virus shedding even after seroconversion in a patient with COVID-19","author":"Liu","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.bj.2020.05.021_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bj.2020.05.021_bib12","article-title":"Factors associated with prolonged viral RNA shedding in patients with COVID-19","author":"Xu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of co-infection between SARS-CoV-2 and other respiratory pathogens","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2020.05.021_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.051","article-title":"Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients","author":"Pan","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.bj.2020.05.021_bib15","doi-asserted-by":"crossref","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients","author":"Okba","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.012","article-title":"Profile of specific antibodies to SARS-CoV-2: the first report","author":"Xiao","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.bj.2020.05.021_bib18","article-title":"Potent human neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Ju","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00461-20","article-title":"Evaluation of nucleocapsid and spike protein-based ELISAs for detecting antibodies against SARS-CoV-2","author":"Liu","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bj.2020.05.021_bib20","article-title":"Reinfection could not occur in SARS-CoV-2 infected rhesus macaques","author":"Bao","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/M20-1301","article-title":"Diagnostic testing for severe acute respiratory syndrome\u2013related coronavirus-2: a narrative review","volume":"172","author":"Cheng","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bj.2020.05.021_bib22","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bj.2020.05.021_bib23","doi-asserted-by":"crossref","first-page":"105938","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bj.2020.05.021_bib24","doi-asserted-by":"crossref","first-page":"m1844","DOI":"10.1136\/bmj.m1844","article-title":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data","volume":"369","author":"Mah\u00e9vas","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bj.2020.05.021_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bj.2020.05.021_bib26","article-title":"Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in COVID-19","author":"Yang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2020.05.021_bib28","series-title":"Interim guidelines for clinical management of SARS-CoV-2 infection","year":"2020"},{"key":"10.1016\/j.bj.2020.05.021_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.bj.2020.05.021_bib30","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bj.2020.05.021_bib31","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3851\/IMP3002","article-title":"Combination therapy with lopinavir\/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome","volume":"21","author":"Kim","year":"2016","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bj.2020.05.021_bib33","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2020.05.021_bib34","series-title":"NIH COVID-19 Treatment Guidelines","year":"2020"},{"key":"10.1016\/j.bj.2020.05.021_bib35","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.bj.2020.05.021_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bj.2020.05.021_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.bj.2020.05.021_bib38","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.bj.2020.05.021_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.bj.2020.05.021_bib40","article-title":"Favipiravir versus Arbidol for COVID-19: a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40262-015-0364-1","article-title":"Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials","volume":"55","author":"Madelain","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bj.2020.05.021_bib42","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.7150\/ijbs.45123","article-title":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2","volume":"16","author":"Zhou","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.bj.2020.05.021_bib43","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bj.2020.05.021_bib44","first-page":"202004168","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.bj.2020.05.021_bib45","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2020.05.021_bib46","article-title":"Favipiravir versus Arbidol for COVID-19: a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib47","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications","author":"Wu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib48","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","author":"Liu","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.bj.2020.05.021_bib49","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of Chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncol"},{"key":"10.1016\/j.bj.2020.05.021_bib51","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.bj.2020.05.021_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.bj.2020.05.021_bib53","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.bj.2020.05.021_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25964","article-title":"Tocilizumab for the treatment of severe coronavirus disease 2019","author":"Alattar","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.bj.2020.05.021_bib55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.bj.2020.05.021_bib56","first-page":"9","article-title":"Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures","volume":"53","author":"Khamitov","year":"2008","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.bj.2020.05.021_bib57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical Features of 69 cases with coronavirus disease 2019 in Wuhan, China","volume":"71","author":"Wang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib58","doi-asserted-by":"crossref","first-page":"119005","DOI":"10.1016\/j.ijpharm.2019.119005","article-title":"Antimicrobial properties of benzalkonium chloride derived polymerizable deep eutectic solvent","volume":"575","author":"Wang","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bj.2020.05.021_bib59","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.05.021_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bj.2020.05.021_bib61","article-title":"Dexamethasone in hospitalized patients with Covid-19-preliminary report","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2020.05.021_bib62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bj.2020.05.021_bib63","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2020.05.021_bib64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bj.2020.05.021_bib65","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3201\/eid1305.061248","article-title":"Inactivated whole virus influenza A (H5N1) vaccine","volume":"13","author":"Vajo","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib67","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease","volume":"84","author":"Ong","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.05.021_bib68","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","article-title":"Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus","volume":"12","author":"Agrawal","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.bj.2020.05.021_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc1932","article-title":"Rapid development of an inactivated vaccine for SARS-CoV-2","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bj.2020.05.021_bib70","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/vaccines2030624","article-title":"Developments in viral vector-based vaccines","volume":"2","author":"Ura","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.bj.2020.05.021_bib71","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bj.2020.05.021_bib72","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bj.2020.05.021_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bj.2020.05.021_bib74","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2018.00171","article-title":"Integrase defective lentiviral vector as a vaccine platform for delivering influenza antigens","volume":"9","author":"Gallinaro","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2020.05.021_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-4690-1-37","article-title":"Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells","volume":"1","author":"Chen","year":"2004","journal-title":"Retrovirology"},{"key":"10.1016\/j.bj.2020.05.021_bib76","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(94)91708-6","article-title":"Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus","volume":"344","author":"Saavedra","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2020.05.021_bib77","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4161\/19490976.2014.969972","article-title":"Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model","volume":"5","author":"Kandasamy","year":"2014","journal-title":"Gut Microb"},{"key":"10.1016\/j.bj.2020.05.021_bib78","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.vaccine.2014.03.022","article-title":"Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice","volume":"32","author":"Takei","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bj.2020.05.021_bib79","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00705-012-1589-z","article-title":"Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71","volume":"158","author":"Yu","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.bj.2020.05.021_bib80","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.celrep.2018.07.035","article-title":"Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors","volume":"24","author":"Kuzmina","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.bj.2020.05.021_bib81","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bj.2020.05.021_bib82","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bj.2020.05.021_bib83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.bj.2020.05.021_bib84","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.bj.2020.05.021_bib85","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","article-title":"Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates","volume":"2","author":"Wang","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib86","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.vaccine.2006.02.025","article-title":"An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.bj.2020.05.021_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.bj.2020.05.021_bib88","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bj.2020.05.021_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bj.2020.05.021_bib90","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bj.2020.05.021_bib91","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib92","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.bj.2020.05.021_bib93","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"10.1016\/j.bj.2020.05.021_bib94","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study","author":"Miller","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib95","article-title":"Association of BCG vaccination policy with prevalence and mortality of COVID-19","author":"Sala","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bj.2020.05.021_bib96","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3201\/eid1509.081336","article-title":"Tokyo-172 BCG vaccination complications, Taiwan","volume":"15","author":"Jou","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bj.2020.05.021_bib97","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.2020.3151","article-title":"Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2020.05.021_bib98","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.1502049","article-title":"Influenza vaccination generates cytokine-induced memory-like NK cells: impact of human Cytomegalovirus infection","volume":"197","author":"Goodier","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.bj.2020.05.021_bib99","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3389\/fimmu.2019.02307","article-title":"Bacille Calmette-guerin vaccine strain modulates the ontogeny of both mycobacterial-specific and heterologous T cell immunity to vaccination in infants","volume":"10","author":"Kiravu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bj.2020.05.021_bib100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2006.08.011","article-title":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro","volume":"25","author":"Kam","year":"2007","journal-title":"Vaccine"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:07:08Z","timestamp":1762420028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417020300858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2319417020300858"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2020.05.021","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2020.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}